Centessa Pharmaceuticals plc (CNTA)
NASDAQ: CNTA · Real-Time Price · USD
14.30
-0.30 (-2.05%)
Sep 6, 2024, 4:00 PM EDT - Market closed
Centessa Pharmaceuticals Revenue
Centessa Pharmaceuticals had revenue of $6.85M in the twelve months ending June 30, 2024. In the year 2023, Centessa Pharmaceuticals had annual revenue of $6.85M.
Revenue (ttm)
$6.85M
Revenue Growth
n/a
P/S Ratio
210.75
Revenue / Employee
$90,171
Employees
76
Market Cap
1.62B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 6.85M | - | - |
Dec 31, 2022 | - | - | - |
Dec 31, 2021 | - | - | - |
Dec 31, 2020 | - | - | - |
Dec 31, 2019 | - | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Indivior | 1.15B |
Warby Parker | 719.93M |
BioCryst Pharmaceuticals | 382.24M |
STAAR Surgical Company | 332.94M |
MannKind | 248.37M |
Nurix Therapeutics | 62.30M |
Recursion Pharmaceuticals | 49.64M |
Syndax Pharmaceuticals | 3.50M |
CNTA News
- 12 days ago - Centessa Pharmaceuticals Announces Late-Breaking Poster Presentation of Non-Human Primate Data for ORX142, a Novel Orexin Receptor 2 (OX2R) Agonist, at the 27th Congress of the European Sleep Research Society (Sleep Europe 2024) - GlobeNewsWire
- 18 days ago - Centessa Pharmaceuticals to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference - GlobeNewsWire
- 26 days ago - Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the Second Quarter of 2024 - GlobeNewsWire
- 3 months ago - Centessa Pharmaceuticals Strengthens Executive Leadership with Appointment of John Crowley CPA, as Chief Financial Officer and Gregory Weinhoff MD MBA, as Chief Business Officer - GlobeNewsWire
- 3 months ago - Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 4 months ago - Centessa Pharmaceuticals Reports Financial Results and Business Highlights for the First Quarter of 2024 - GlobeNewsWire
- 4 months ago - Centessa: Hemophilia B Data Readout In 2024 Is Major Turning Point - Seeking Alpha
- 4 months ago - Centessa Pharmaceuticals Announces Pricing of $100 Million Public Offering of American Depositary Shares - GlobeNewsWire